Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals Inc.
WKN: A2ACMZ / Symbol: IONS / Name: Ionis Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
68,84 €
0,92 %
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $49.00.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at Needham & Company LLC from $70.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) was given a new $90.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $89.00 price target on the stock, up previously from $85.00.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at Royal Bank Of Canada from $80.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at TD Cowen from $59.00 to $99.00. They now have a "buy" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at Piper Sandler from $70.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at HC Wainwright from $100.00 to $110.00. They now have a "buy" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at Bank of America Corporation from $86.00 to $97.00. They now have a "buy" rating on the stock.
Ratings data for IONS provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Johnson & Johnson diskutieren